These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 12359770

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases.
    van der Pluijm G, Sijmons B, Vloedgraven H, Deckers M, Papapoulos S, Löwik C.
    J Bone Miner Res; 2001 Jun; 16(6):1077-91. PubMed ID: 11393785
    [Abstract] [Full Text] [Related]

  • 6. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
    Mbalaviele G, Dunstan CR, Sasaki A, Williams PJ, Mundy GR, Yoneda T.
    Cancer Res; 1996 Sep 01; 56(17):4063-70. PubMed ID: 8752180
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix.
    Eckhardt BL, Parker BS, van Laar RK, Restall CM, Natoli AL, Tavaria MD, Stanley KL, Sloan EK, Moseley JM, Anderson RL.
    Mol Cancer Res; 2005 Jan 01; 3(1):1-13. PubMed ID: 15671244
    [Abstract] [Full Text] [Related]

  • 9. RANK ligand is a prerequisite for cancer-associated osteolytic lesions.
    Kitazawa S, Kitazawa R.
    J Pathol; 2002 Oct 01; 198(2):228-36. PubMed ID: 12237883
    [Abstract] [Full Text] [Related]

  • 10. Matrix metalloproteinase-1 is a crucial bone metastasis factor in a human breast cancer-derived highly invasive cell line.
    Okuyama N, Matsumine A, Kosugi R, Wakabayashi H, Uchida A.
    Oncol Rep; 2008 Dec 01; 20(6):1497-504. PubMed ID: 19020733
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
    Tan M, Yao J, Yu D.
    Cancer Res; 1997 Mar 15; 57(6):1199-205. PubMed ID: 9067293
    [Abstract] [Full Text] [Related]

  • 12. Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer.
    Singh B, Berry JA, Vincent LE, Lucci A.
    J Surg Res; 2006 Jul 15; 134(1):44-51. PubMed ID: 16678856
    [Abstract] [Full Text] [Related]

  • 13. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, Que I, Schwaninger R, Rentsch C, Ten Dijke P, Cleton-Jansen AM, Driouch K, Lidereau R, Bachelier R, Vukicevic S, Clézardin P, Papapoulos SE, Cecchini MG, Löwik CW, van der Pluijm G.
    Cancer Res; 2007 Sep 15; 67(18):8742-51. PubMed ID: 17875715
    [Abstract] [Full Text] [Related]

  • 14. cAMP-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destruction.
    Son J, Lee JH, Kim HN, Ha H, Lee ZH.
    Biochem Biophys Res Commun; 2010 Jul 23; 398(2):309-14. PubMed ID: 20599715
    [Abstract] [Full Text] [Related]

  • 15. Osteoactivin promotes breast cancer metastasis to bone.
    Rose AA, Pepin F, Russo C, Abou Khalil JE, Hallett M, Siegel PM.
    Mol Cancer Res; 2007 Oct 23; 5(10):1001-14. PubMed ID: 17951401
    [Abstract] [Full Text] [Related]

  • 16. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
    Liersch T, Gatzemeier W, Scharnberg P, Jürgens B, Wörmann B, Becker H, Rauschecker HF, Hiddemann W, Wulf GG.
    Langenbecks Arch Chir Suppl Kongressbd; 1998 Oct 23; 115(Suppl I):277-80. PubMed ID: 14518259
    [Abstract] [Full Text] [Related]

  • 17. ALCAM, activated leukocyte cell adhesion molecule, influences the aggressive nature of breast cancer cells, a potential connection to bone metastasis.
    Davies S, Jiang WG.
    Anticancer Res; 2010 Apr 23; 30(4):1163-8. PubMed ID: 20530423
    [Abstract] [Full Text] [Related]

  • 18. COX-2 induces IL-11 production in human breast cancer cells.
    Singh B, Berry JA, Shoher A, Lucci A.
    J Surg Res; 2006 Apr 23; 131(2):267-75. PubMed ID: 16457848
    [Abstract] [Full Text] [Related]

  • 19. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].
    Lin Y, Wang SM, Huang RP.
    Zhonghua Yi Xue Za Zhi; 2005 Jun 01; 85(20):1419-23. PubMed ID: 16029657
    [Abstract] [Full Text] [Related]

  • 20. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
    Jackson JG, Zhang X, Yoneda T, Yee D.
    Oncogene; 2001 Nov 01; 20(50):7318-25. PubMed ID: 11704861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.